TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.92M | -30.05M | -29.29M | -27.76M | -23.50M |
| Total Depreciation and Amortization | 80.70K | 71.30K | 66.40K | 74.20K | 96.40K |
| Total Amortization of Deferred Charges | 481.40K | 481.40K | 171.40K | 840.20K | 1.26M |
| Total Other Non-Cash Items | 6.39M | 5.02M | 5.86M | 4.16M | 3.37M |
| Change in Net Operating Assets | -3.33M | -3.15M | -1.48M | 5.88M | 3.14M |
| Cash from Operations | -27.30M | -27.63M | -24.67M | -16.81M | -15.63M |
| Capital Expenditure | -82.30K | -76.20K | -69.70K | -69.70K | -100.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -150.90K | -1.26M | -2.06M | -7.25M | -7.10M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -233.20K | -1.34M | -2.13M | -7.32M | -7.20M |
| Total Debt Issued | 3.00M | 3.00M | 0.00 | 9.50M | 23.67M |
| Total Debt Repaid | -2.59M | -2.38M | -576.30K | -- | -- |
| Issuance of Common Stock | 28.92M | 21.92M | 15.75M | 16.58M | 7.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.40K | -8.40K | -6.30K | -4.20K | -2.10K |
| Other Financing Activities | -1.71M | -2.61M | -5.26M | -5.74M | -6.62M |
| Cash from Financing | 27.62M | 19.93M | 9.91M | 20.34M | 24.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.30K | -9.04M | -16.90M | -3.80M | 1.76M |